Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanika Sehgal

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Microbiomes|March 19, 2026
Live biotherapeutic products: a capstone for prevention of recurrent <i>Clostridiodes difficile</i> infectionKanika Sehgal, Paul Feuerstadt
Expert Review of Gastroenterology & Hepatology|July 30, 2021
Gut microbiota: a target for intervention in obesityKanika Sehgal, Sahil Khanna
Therapeutic Advances in Gastroenterology|March 22, 2021
Gut microbiome and <i>Clostridioides difficile</i> infection: a closer look at the microscopic interfaceKanika Sehgal, Sahil Khanna
Therapeutic Advances in Gastroenterology|May 17, 2021
Immune response against <i>Clostridioides difficile</i> and translation to therapyKanika Sehgal, Sahil Khanna
Intestinal Research|November 29, 2020
Gut microbiome and checkpoint inhibitor colitisKanika Sehgal, Sahil Khanna
Translational Gastroenterology and Hepatology|November 29, 2023
The real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent <i>Clostridiodes difficile</i>Kanika Sehgal, Paul Feuerstadt
Alimentary Pharmacology & Therapeutics|September 2, 2024
Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trialKanika Sehgal, Dennis L Shung
Therapeutic Advances in Gastroenterology|June 9, 2021
The interplay of <i>Clostridioides difficile</i> infection and inflammatory bowel diseaseKanika Sehgal, Devvrat Yadav, Sahil Khanna
JAMA|August 8, 2022
Treatment of Clostridioides difficile InfectionKanika Sehgal, Adam S Cifu, Sahil Khanna
Infectious Disease Clinics of North America|August 12, 2025
Making Sense of Differing Guidelines for Clostridioides difficile InfectionKanika Sehgal, Paul Feuerstadt, Mark H Wilcox
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Microbiomes|March 19, 2026
Live biotherapeutic products: a capstone for prevention of recurrent <i>Clostridiodes difficile</i> infectionKanika Sehgal, Paul Feuerstadt
Expert Review of Gastroenterology & Hepatology|July 30, 2021
Gut microbiota: a target for intervention in obesityKanika Sehgal, Sahil Khanna
Therapeutic Advances in Gastroenterology|March 22, 2021
Gut microbiome and <i>Clostridioides difficile</i> infection: a closer look at the microscopic interfaceKanika Sehgal, Sahil Khanna
Therapeutic Advances in Gastroenterology|May 17, 2021
Immune response against <i>Clostridioides difficile</i> and translation to therapyKanika Sehgal, Sahil Khanna
Intestinal Research|November 29, 2020
Gut microbiome and checkpoint inhibitor colitisKanika Sehgal, Sahil Khanna
Translational Gastroenterology and Hepatology|November 29, 2023
The real efficacy of microbiota restoration following standard of care antimicrobial in patients with recurrent <i>Clostridiodes difficile</i>Kanika Sehgal, Paul Feuerstadt
Alimentary Pharmacology & Therapeutics|September 2, 2024
Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low-dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trialKanika Sehgal, Dennis L Shung
Therapeutic Advances in Gastroenterology|June 9, 2021
The interplay of <i>Clostridioides difficile</i> infection and inflammatory bowel diseaseKanika Sehgal, Devvrat Yadav, Sahil Khanna
JAMA|August 8, 2022
Treatment of Clostridioides difficile InfectionKanika Sehgal, Adam S Cifu, Sahil Khanna
Infectious Disease Clinics of North America|August 12, 2025
Making Sense of Differing Guidelines for Clostridioides difficile InfectionKanika Sehgal, Paul Feuerstadt, Mark H Wilcox
Pageof 2